Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has granted a 60 percent rating for the Veteran's rash and lesions associated with pruritis ani from March 17, 2015. The condition required constant or near-constant systemic therapy throughout the period on appeal.

The deciding factor: The Veteran's skin disorder required constant or near-constant use of hydroxyzine, an oral antihistamine, which is now considered a systemic therapy under new VA regulations effective August 13, 2018.

Claimed conditions
Rash and lesions associated with pruritis ani
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
May 24, 2021
Citation
21031632

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 21031632.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.